David Goldblatt

22PUBLICATIONS
132CO-AUTHORS
Innate immunityCardiology (incl. cardiovascular diseases)Preventative health careInfant and child healthMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 12, 2026
A randomized, placebo-controlled trial of 13-valent pneumococcal conjugate vaccination to accelerate immune recovery after sepsis.

|May 22, 2026
Beyond survival: Multisystem long-term outcomes following HSCT in chronic granulomatous disease.

|Nov 25, 2025
Safety and Immunogenicity of a Klebsiella pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Administered to Healthy Adults: A First-in-Human Phase I/II Randomized and Controlled Study.

C Alaimo, N Karaky, R Lawrence

|Nov 24, 2025
Immune transcriptomic differences in paediatric patients with SARS-CoV-2 compared to other lower respiratory tract infections.

Negusse Tadesse Kitaba, Lesley Workman, Cheryl Cohen

|Jun 12, 2025
The development of functional opsonophagocytic assays to evaluate antibody responses to Klebsiella pneumoniae capsular antigens.

Robert Lawrence, Emma Bownes, Marina Johnson

|Sep 27, 2024
Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial.

Katherine E Gallagher, Ruth Lucinde, Christian Bottomley

Pageof 4

Frequent Collaborators

2 joint publications

Mala K Maini

2 joint publications

Cheryl Cohen

2 joint publications

Elena Mitsi

2 joint publications

Leo Swadling